Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Connective and Soft Tissue » Neoplasms, Connective Tissue
Diseases [C] » Skin and Connective Tissue Diseases [C17] » Connective Tissue Diseases » Neoplasms, Connective Tissue
Description
Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue. MeSH
Hierarchy View
Subtype Terms (16)
Chondroblastoma
1 approved drug
Chondroma
1 approved drug
Chondrosarcoma
55 drugs (36 approved, 19 experimental)
Endometrial Stromal Tumors
1 approved drug
Gastrointestinal Stromal Tumors
88 drugs (48 approved, 40 experimental)
Giant Cell Tumors
5 drugs (4 approved, 1 experimental)
Mastocytosis
24 drugs (15 approved, 9 experimental)
Myxoma
2 approved drugs
Neoplasms, Bone Tissue
3 approved drugs
Neoplasms, Fibrous Tissue
2 approved drugs
Sarcoma, Clear Cell
36 drugs (22 approved, 14 experimental)
Sarcoma, Synovial
66 drugs (31 approved, 35 experimental)
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (3)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
